Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK1 | P04629 | 10/20 | 0.43 |
| ▸ | DRD2 | P14416 | 2/20 | 0.40 |
| ▸ | DRD4 | P21917 | 2/20 | 0.40 |
| ▸ | DRD3 | P35462 | 2/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.39 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | HTR3A | P46098 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | MC4R | P32245 | 3/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1975870 | 0.87 | PDE4B (0.46) | NTRK1DRD2DRD4DRD3 | |
| SCHEMBL19180711 | 0.87 | PDE4B (0.46) | NTRK1DRD2DRD4DRD3 | |
| SCHEMBL2016338 | 0.87 | PDE4B (0.46) | NTRK1DRD2DRD4DRD3 | |
| SCHEMBL16780829 | 0.86 | NTRK1 (0.44) | NTRK1DRD2DRD4DRD3MAPK1 | |
| SCHEMBL1975431 | 0.81 | DRD2 (0.46) | NTRK1DRD2DRD4DRD3 | |
| SCHEMBL2226900 | 0.81 | DRD2 (0.46) | NTRK1DRD2DRD4DRD3 | |
| SCHEMBL2413984 | 0.81 | DPP4 (0.41) | NTRK1DRD2DRD4DRD3 | |
| SCHEMBL2013229 | 0.79 | NTRK1 (0.49) | NTRK1 | |
| SCHEMBL1990123 | 0.79 | NTRK1 (0.49) | NTRK1 | |
| SCHEMBL19271023 | 0.79 | NTRK1 (0.52) | NTRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011073160-A1 | PYRROLIDINE DERIVATIVES AS NK - 3 RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2011-06-23 | — | — | WO | disclosed |